Vitaspis Cellasyn 400 (coQ10) 400mg 30.caps - Food supplement with coenzyme Q10 400mg
Special Price
€39.50
Regular Price
€46.70
In stock
SKU
1011549
Vitaspis Cellasyn 400 (coQ10) 400mg 30.caps - Food supplement with coenzyme Q10 400mg
Cellasyn 400 Vitaspis Health Care
Contains: 30 capsules
Sugar, gluten & lactose free
Nutrition facts: CELLASYN 400 contains high purity coenzyme Q10 400mg
Ingredients: Coenzyme Q10, silicon dioxide (anti-caking agent), magnesium stearate, hydroxypropyl methylcellulose.
Recommended dosage: 1 capsule or according to the doctor's instructions.
REGISTRATION NUMBER: 122142/16-11-2022
Coenzyme Q10 is an essential element of the body for energy production, it achieves this by converting glucose and oxygen into energy in the mitochondria and then transports it throughout the body.
Q10 levels decrease over time. ( Figure 1 )
Figure 1
In addition, low Co Q10 levels are seen in patients with chronic health problems.
Coenzyme Q10
It protects both cell membranes and other cellular elements as well as DNA from oxidative damage.
It has a beneficial effect on neurodegenerative diseases, such as Parkinson's Disease, mitochondrial syndromes, Down Syndrome, Motor Neurone Disease, Myoencephalopathies and Alzheimer's.
It increases the levels of energy and oxygen in the body, enhancing resistance to exercise and contributes positively to chronic fatigue.
It supports the good health of the teeth and gums
It actively participates in anti-aging by destroying lipid peroxide radicals.
A recent study of high-dose Q10 compared to placebo in post-covid-19 patients showed a significant reduction in neurological and musculoskeletal symptoms.
It can improve insulin resistance in patients with type 2 diabetes.
It improves the clinical picture in fibromyalgia.
Effective reduction in signs of oxidative stress in Huntington's Disease.
Coenzyme Q10 400mg is also administered on the basis of a medical directive in neurodegenerative diseases.
Bibliography
(9) Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol. 2008;4:600–609
(6) Di Giovanni S, Mirabella M, Spinazzola A, Crociani P, Silvestri G, et al. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology. 2001;57:515–518.
(3)Adarsh K, Kaur H, Mohan V. Coenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM) Biofactors. 2008;32:145–149.
(4) Golbidi S, Ebadi SA, Laher I. Antioxidants in the treatment of diabetes. Curr Diabetes Rev. 2011;7:106–125. [PubMed] [Google Scholar]
(5) Greenberg S, Frishman WH. Co-enzyme Q10 a new drug for cardiovascular disease. J Clin Pharmacol. 1990;30:596–608.
(1,2) Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BG, et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain. 2007;130:2037–2044
(7)Role of Coenzyme Q10 in Health and Disease: An Update on the Last 10 Years (2010-2020).
(8)Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition Richard Kones 1
(10)Hargreaves IP, Duncan AJ, Heales SJ, Land JM. The effect of HMG-CoA reductase inhibitors on coenzyme Q10 possible biochemical/clinical implications. Drug Saf. 2005;28:659–676.
(11) Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002;56:1137–1142.
Yagnik D. Coenzyme Q10 and Vitamin D Interventions Could Ameliorate COVID-19 Related Cellular Bioenergetic Dysfunction and Cytokine Storms. J Immunological Sci. (2021); 5(3)
(12) High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trialKS Hansen, TH Mogensen, J Agergaard... – The Lancet Regional..., 2022
(13) Mizuno K, Tanaka M, Nozaki S, Mizuma H, Ataka S, Tahara T, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, fatigue. Nutrition. 2008 Apr;24(4):293-9. doi: 10.1016/j.nut.2007.12.007. Epub 2008 Feb 13. Erratum in: Nutrition. 2008 Jun;24(6):616. Kajimoto O, Watanabe Y. Antifatigue effects of coenzyme Q10 during exercise
30 caps
Manufacturer | Vitaspis |
---|---|
Pieces | 1 |
ean13 | 735745337653 |
Capsules | 30 |
available in 1-3 working days | No |
Write Your Own Review